Pathogenic variants in the transporter gene SLC12A5 also result in early onset epilepsy with refractory seizures and delayed development.44 Our two cases were both responders at 3 months but one lost efficacy later while in the other response persisted for 2 years. The gene discussed is SLC12A5; the disease is epilepsy.